Follow
Dr. Peter V. Markov
Title
Cited by
Cited by
Year
The evolution of SARS-CoV-2
PV Markov, M Ghafari, M Beer, K Lythgoe, P Simmonds, NI Stilianakis, ...
Nature Reviews Microbiology 21 (6), 361-379, 2023
3322023
Genetic history of hepatitis C virus in East Asia
OG Pybus, E Barnes, R Taggart, P Lemey, PV Markov, B Rasachak, ...
Journal of virology 83 (2), 1071-1082, 2009
2922009
Genetic history of hepatitis C virus in East Asia
OG Pybus, E Barnes, R Taggart, P Lemey, PV Markov, B Rasachak, ...
Journal of virology 83 (2), 1071-1082, 2009
2922009
Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa
PV Markov, J Pepin, E Frost, S Deslandes, AC Labbe, OG Pybus
Journal of General Virology 90 (9), 2086-2096, 2009
1242009
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
PV Markov, A Katzourakis, NI Stilianakis
Nature Reviews Microbiology 20 (5), 251-252, 2022
1122022
Investigating the endemic transmission of the hepatitis C virus
OG Pybus, PV Markov, A Wu, AJ Tatem
International journal for parasitology 37 (8-9), 839-849, 2007
892007
Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam
PV Markov, TJ van de Laar, XV Thomas, SJ Aronson, CJ Weegink, ...
Journal of virology 86 (14), 7677-7687, 2012
752012
Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants
PV Markov, NS Crowcroft
Epidemiology & Infection 135 (1), 17-26, 2007
272007
Evolution and diversity of the human leukocyte antigen (HLA)
PV Markov, OG Pybus
Evolution, medicine, and public health 2015 (1), 1-1, 2015
262015
Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation
R Rose, PV Markov, TT Lam, OG Pybus
Infection, Genetics and Evolution 20, 418-421, 2013
202013
Covid-19: An urgent call for global" vaccines-plus" action
T Greenhalgh, S Griffin, D Gurdasani, A Hamdy, A Katzourakis, M McKee, ...
BMJ: British Medical Journal 376, 2022
172022
Evidence of SARS-CoV-2 bacteriophage potential in human gut microbiota
M Petrillo, M Querci, C Brogna, J Ponti, S Cristoni, PV Markov, A Valsesia, ...
F1000Research 11, 292, 2022
102022
Adaptation to host cell environment during experimental evolution of Zika virus
V Grass, E Hardy, K Kobert, SR Talemi, E Décembre, C Guy, PV Markov, ...
Communications Biology 5 (1), 1115, 2022
62022
Hepatitis C virus genotype 4 in England: diversity and demographic associations
SL Ngui, L Brant, PV Markov, JP Tung, OG Pybus, CG Teo, ME Ramsay
Journal of Medical Virology 87 (3), 417-423, 2015
42015
Hepatitis A virus infection control: an audit of practice in England and Wales prior to guidelines being published
PV Markov, SN Ahmed, NS Crowcroft
Communicable disease and public health 6, 30-33, 2003
32003
A mathematical model for the within-host (re) infection dynamics of SARS-CoV-2
L Schuh, PV Markov, VM Veliov, NI Stilianakis
Mathematical Biosciences 371, 109178, 2024
2024
A mathematical model for the within-host (re) infection dynamics of SARS-CoV-2 (preprint)
L Schuh, PV Markov, VM Veliov, NI Stilianakis
2023
Hepatitis C virus genotype 4 in England: diversity and demographic associations.
NSL Ngui SiewLin, L Brant, PV Markov, JP Tung, OG Pybus, ...
2015
The Evolutionary Epidemiology of the Hepatitis C Virus.
PV Markov, RR Gray, J Iles, OG Pybus
In: Morand S, Krasnov B, Littlewood T. Eds. Parasite diversity and …, 2015
2015
The adaptation of chronic viral infections to human genetic diversity
OG Pybus, PV Markov
IMMUNOLOGY 135, 30-30, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–20